Chronic obstructive pulmonary disease in women;EPOC en la mujer

Archivos de Bronconeumologia

Volumn 46, Issue SUPPL. 3, 2010, Pages 23-27

  de Torres Tajes, Juan Pablo ^a   Macario, Ciro Casanova ^b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

COPD; Differential features; Sex

Indexed keywords

CYTOCHROME P450;

ANXIETY; ARTICLE; BIOMASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DEPRESSION; DISEASE EXACERBATION; DYSPNEA; EMPHYSEMA; ENVIRONMENTAL EXPOSURE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALNUTRITION; OXYGEN THERAPY; PHENOTYPE; PREVALENCE; PULMONARY REHABILITATION; QUALITY OF LIFE; SEX DIFFERENCE; TOBACCO; WOMEN'S HEALTH;

FEMALE; HUMANS; MALE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEX FACTORS;

EID: 77953890802     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S0300-2896(10)70023-5     Document Type: Article

References (64)

1. Jamal A., Ward E., Hao Y., Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005, 294:1255-1259.
2. Centers for Disease Control and Prevention Cigarette smoking among adults- United States. JAMA. 1995;273:369-70.
3. Gold D.R., Wang X., Wypij D., Speizer F.E., Ware J.H., Dockery D.W. Effects of cigarette smoking on lung function in adolescent boy and girls. N Engl J Med 1996, 335:931-937.
4. Mannino D.M., Homa D.M., Akinbami L.J., Ford E.S., Redd S.C. Chronic Pulmonary Disease Surveillance- United States, 1971-2000. MMWR 2002, 51:SS1-16.
5. Mannino D.M. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002, 121:121S-126S.
6. Prescott E., Bjerg A.M., Andersen P.K., Lange P., Vestbo J. Gender diferences in smoking effects on lung function and risk of hospitalization for COPD: results from de Danish longitudinal population study. Eur Respir J 1997, 10:822-827.
7. Chapman K.R., Tashkin D.P., Pye D. Gender Bias in the Diagnosis of COPD. Chest 2001, 119:1691-1695.
8. Miravitlles M., De la Roza C., Naberan K., Lamban M., Gobartt E., Martín A., et al. Attitudes toward the diagnosis of chronic obstructive pulmonary disease in primary care. Arch Bronconeumol 2006, 42:3-8.
9. Bruce N, Pérez-Padilla R, Albalak R. The health effects of indoor air pollution exposure in developing countries. Geneva, Switzerland: World Health Organization; 2002. Publication No. WHO(2002)/SDE/OEH/02.05, Geneva Blanc PD.
10. Becklake M.R., Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax 1999, 54:1119-1138.
11. Xu X., Li B., Wang L. Gender difference in smoking effects on adult pulmonary function. Eur Respir J 1994, 7:477-483.
12. Xu X., Weiss S.T., Rijcken B., Shouten J.P. Smoking, changes in smoking habits, and rate of decline in FEV1: new insights into gender differences. Eur Resp J 1994, 7:1056-1061.
13. Anthonisen N.R. Lessons from Lung Health Study. Proc Am Thorac Soc 2004, 1:143-145.
14. Zieliñski J., Bednarek M. Early Detection of COPD in a High-Risk Population Using Spirometric Screenig. Chest 2001, 119:731-736. The Know the Age of Your Lung Study Group.
15. Blanc P.D. The role of household exposure in lung disease among women. Eur Respir Mon 2003, 25:118-130.
16. Ramirez-Venegas A., Sansores R.H., Perez-Padilla R., Regalado J., Velazquez A., Sanchez C., et al. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med 2006, 173:393-397.
17. Nishimura K., Izumi T., Tsukino M., Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002, 121:1434-1440.
18. Pollution atmosphérique et affections respiratoires chroniques ou á répétition. Bull Eur Physiopathol Respir 1982, 18:87-99. PAARC. Group Coopératif.
19. De Torres J.P., Casanova C., Hernandez C., Abreu J., Aguirre-Jaime A., Celli B.R. Gender and COPD in patients attending a pulmonary clinic. Chest 2005, 128:2012-2016.
20. De Torres J.P., Casanova C., Montejo de Garcini A., Aguirre-Jaime A., Celli B.R. Gender and respiratory factors associated with dyspnea in chronic obstructive pulmonary disease. Respir Res 2007, 8:18.
21. Gift A.G., Shepard C.E. Fatigue and other symptoms in patients with chronic obstructive pulmonary disease: do women and men differ?. JOGNN 1999, 28:201-208.
22. Leynaert B., Bousquet J., Henry C., Liard R., Neukirch F. Is bronchial hyperresponsiveness more frequent in women than in men? A population based study. Am J Respir Crit Care Med 1997, 156:1413-1420.
23. Kanner R.E., Connet J.E., Murray D.A., Buist A.S., Lee W.W., Tashkin D.P., et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD. For the Lung Health Study. Am J Respir Crit Care Med 1994, 150:956-961.
24. Silva G.E., Sherrill D.L., Guerra S., Barbee R.A. Asthma as a Risk Factor for COPD in a Longitudinal Study. Chest 2004, 126:59-65.
25. Donaldson G.C., Seemungal T.A., Patel I.S., Bhowmik A., Wilkinson T.M., Hurst J.R., et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005, 128:1995-2004.
26. Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med 2002, 166:111-117. ATS Statement.
27. Troosters T., Gosselink R., Decramer M. Six Minute Walking Distance In Elderly Normal Subjects. Eur Respir J 1999, 14:270-274.
28. Parr D.G., Stoel B.C., Stolk J., Stockley R.A. Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency. Thorax 2006, 61:485-490.
29. Martinez F.J., Curtis J.L., Sciurba F., Mumford J., Giardino N.D., Weinmann G., et al. Gender Differences in Severe Pulmonary Emphysema. Am J Respir Crit Care Med 2007, 176:243-252.
30. Dransfield M.T., Washko G.R., Foreman M.G., Estepar R.S.J., Reilly J., Bailey W.C. Gender differences in the severity of CT emphysema in COPD. Chest 2007, 132:464-470.
31. Mair G., Miller J.J., McAllister D., Maclay J., Connell M., Murchison J.T., et al. Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers. Eur Respir J 2009, 33:536-542.
32. Casanova C., Cote C., De Torres J.P., Aguirre-jaime A., Marin J.M., Pinto-Plata V., et al. The Inspiratory to Total Lung Capacity Ratio Predicts Mortality in Patients with COPD. Am J Respir Crit Care Med 2004, 171:591-597.
33. De Torres J.P., Cote C.G., López M.V., Casanova C., Díaz O., Marin J.M., et al. Sex differences in mortality in patients with COPD. Eur Respir J 2009, 33:528-535.
34. Schols A.M., Slagen J., Volovics L., Wouters E.F.M. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 15:1791-1797.
35. Schols A.M., Wouters E.F., Soeters P.B., Westerterp K.R. Body composition by bioelectricalimpedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991, 53:421-424.
36. Vermeeren M.A., Creutzberg E.C., Schols A.M., Postma D.S., Pieters W.R., Roldaan A.C., et al. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med 2006, 100:1349-1355. COSMIC Study Group.
37. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbation. Acad Emerg Med. 2005;12:1173-9.
38. Tsai C.L., Clark S., Cydulka R.K., Rowe B.H., Camargo C.A. Factors associated with hospital admission among emergency department patients with chronic obstructive pulmonary disease exacerbation. Acad Emerg Med 2007, 14:6-14.
39. Kollef M.H., O'Brien J.D., Silver P. The impact of gender on outcome from mechanical ventilation. Chest 1997, 111:434-441.
40. Osman L.M., Godden D.J., Friend J.A.R., Legge J.S., Douglas J.G. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997, 52:67-71.
41. Ferrer M., Alonso J., Prieto L., Plaza V., Monso E., Marrades R., et al. Validity and realiability of the Spanish version of the St George's Respiratory Questionnaire. Eur Respir J 1996, 9:1160-1166.
42. Tsukino M., Nishimura K., Ikeda A., Koyama H., Mishima M., Izumi T. Physiologyc factors that determine the Health-Related Quality of Life in patients with COPD. Chest 1996, 110:896-903.
43. Larson J., Kirchgessner J., McCutcheon J. Quality of Life in chronic obstructive pulmonary disease: Gender differences (Abstract). Amer J Respir Crit Care Med 1998, 157(Part 2):A869.
44. De Torres J.P., Casanova C., Hernández C., Abreu J., Montejo de Garcini A., Aguirre-Jaime A., et al. Gender associated differences in determinants of quality of life in patients with COPD: a case series study. Health Qual Life Outcomes 2006, 4:72.
45. Agusti A. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005, 2:367-370.
46. Almagro P., López García F., Cabrera F., Montero L., Morchón D., Díez J., Soriano J. Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study. Respir Med 2010, 104:253-259. GRupo Epoc De La Sociedad EspañOla De Medicina Interna.
47. Fan V.S., Ramsey S.D., Giardino N.D., Make B.J., Emery C.F., Diaz P.T., et al. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med 2007, 167:2345-2353. National Emphysema Treatment Trial (NETT) Research Group.
48. Di Marco F., Verga M., Reggente M., Maria Casanova F., Santus P., Blasi F., et al. Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med 2006, 100:1767-1774.
49. Ng T.P., Niti M., Tan W.C., Cao Z., Ong K.C., Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007, 167:60-67.
50. Ben-Zaken Cohen S., Paré P.D., Paul Man S.F., Sin D.D. COPD and Lung Cancer in women: examining sex differences in cigarette smoke metabolism. Am J Respir Crit Care Med 2007, 176:113-120.
51. Connett J.E., Murray R.P., Buist A.S., Wise R.A., Bailey W.C., Lindgren P.G., et al. Changes in smoking status affect women more than men: results of the Lung Health Study. Am J Epidemiol 2003, 157:973-979. Lung Health Study Research Group.
52. Singleton J.K., Levin R.F., Feldman H.R., Truglio-Londrigan M. Evidence for smoking cessation: Implications for gender-specific strategies. Worldviews Evid Based Nurs 2005, 2:63-74.
53. Goodman D.E., Israel E., Rosenberg M., Johnston R., Weiss S.T., Drazen J.M. The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med 1994, 150:1256-1266.
54. Vestbo J., Soriano J.B., Anderson J.A., Calverley P., Pauwels R., Jones P. Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD. Respir Med 2004, 98:1045-1050. TRISTAN Study Group.
55. Soriano J.B., Sin D.D., Zhang X., Camp P.G., Anderson J.A., Anthonisen N.R., et al. A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. Chest 2007, 131:682-689.
56. Ries A.L., Bauldoff G.S., Carlin B.W., Casaburi R., Emery C.F., Mahler D.A., et al. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 2007, 131:4S-42S.
57. Cote C.G., Celli B.R. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 2005, 26:630-636.
58. Foy C.G., Rejeski J., Berry M.J., Zaccaro D., Woodard C.M. Gender moderates the effects of exercise therapy on health- related quality of life among COPD patients. Chest 2001, 119:70-76.
59. Paz-Diaz H., Montes de Oca M., Lopez J.M., Celli B.R. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil 2007, 86:30-36.
60. Miyamoto K., Aida A., Nishimura M., Aiba M., Kira S., Kawakami Y. Gender effect on prognosis of patients receiving long-term home oxygen therapy. The Respiratory Failure Research Group in Japan. Am J Respir Crit Care Med 1995, 152:972-976.
61. Franklin K.A., Gustafson T., Ranstam J., Strom K. Survival and future need of long-term oxygen therapy for chronic obstructive pulmonary disease-gender differences. Respir Med 2007, 101:1506-1511.
62. Machado M.C., Krishnan J.A., Buist S.A., Bilderback A.L., Fazolo G.P., Santarosa M.G., et al. Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 174:524-529.
63. Celli B.R., Calverley P.M., Rennard S.I., Wouters E.F., Agusti A., Anthonisen N., et al. Proposal for a multidimensional staging system for chronic obstructive pulmonary disease. Respir Med 2005, 99:1546-1554.
64. De Torres J.P., Casanova C., De Garcini A.M., Jaime A.A., Celli B.R. COPD heterogeneity: gender differences in the multidimensional BODE index. Int J Chron Obstruct Pulmon Dis 2007, 2:151-155.